Maybank Securities

Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy' - THE EDGE SINGAPORE

Broker's Calls

Raffles Medical's 1HFY2023 results likely to have set a new baseline of profitability, analysts keep 'buy'

Raffles Medical is Maybank’s preferred pick in the healthcare sector.
Lower DPU but positive rental reversions for Mapletree Industrial Trust leave analysts mixed - THE EDGE SINGAPORE

Broker's Calls

Lower DPU but positive rental reversions for Mapletree Industrial Trust leave analysts mixed

The trust’s DPU dipped 2.9% y-o-y but rose 1.8% q-o-q to 3.39 cents for the 1QFY2024.
CapitaLand Ascott Trust 'top pick' of some analysts following 1HFY2023 results, DPS up 19% y-o-y - THE EDGE SINGAPORE

Broker's Calls

CapitaLand Ascott Trust 'top pick' of some analysts following 1HFY2023 results, DPS up 19% y-o-y

CLAS’s revenue per available unit (RevPAU) for 2QFY2023 ended June was at 98% of pre-pandemic levels, or 2QFY2019.
Analysts lukewarm on Suntec REIT as outlook moderates - THE EDGE SINGAPORE

Broker's Calls

Analysts lukewarm on Suntec REIT as outlook moderates

The analysts expect a negative share price reaction on the earnings miss.
CSE’s profitability projected to surge 250% y-o-y in FY2023 on oil & gas upcycle: Maybank Securities - THE EDGE SINGAPORE

Broker's Calls

CSE’s profitability projected to surge 250% y-o-y in FY2023 on oil & gas upcycle: Maybank Securities

Corporate share-buybacks are also a possibility for this “undervalued” counter, says analyst Jarick Seet.
Maybank Securities maintains ‘buy’ call on Grab, as slimmer losses enable a focus on growth - THE EDGE SINGAPORE

Broker's Calls

Maybank Securities maintains ‘buy’ call on Grab, as slimmer losses enable a focus on growth

Maybank Securities maintains “buy” on Grab Holdings ahead of its 1HFY2023 ended June results.

Broker's Calls

Higher funding costs, lower loan volumes expected at local banks' 2QFY2023 results; Maybank prefers DBS

Maybank's Thilan Wickramsinghe sees potential for higher dividends, albeit only in 4QFY2023.
×